Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Cited by (902)

Items 301–400 of 902

1. HDAC6 deacetylates alpha tubulin in sperm and modulates sperm motility in Holtzman rat
   Sweta Parab, Omshree Anil Shetty, Reshma Gaonkar, Nafisa Balasinor, Vrinda V. Khole, Priyanka P. Parte · 2014 · Cell and Tissue Research
2. HDAC6 as a potential therapeutic target for peripheral nerve disorders
   Robert Ciarán Prior, Lawrence Van Helleputte, Yvonne Eileen Klingl, Ludo Van Den Bosch · 2018 · Expert Opinion on Therapeutic Targets
3. HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics
   Carlla Assis Araújo-Silva, Wanderley de Souza, Érica S. Martins-Duarte, Rossiane Cláudia Vommaro · 2020 · International Journal for Parasitology Drugs and Drug Resistance
4. Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)
   Davide Bonanni, Andrea Citarella, Davide Moi, Luca Pinzi, Elisa Bergamini, Giulio Rastelli · 2021 · Current Medicinal Chemistry
5. Mechanochemical Fischer indolisation: an eco-friendly design for a timeless reaction
   Andrea Porcheddu, Rita Mocci, Margherita Brindisi, Federico Cuccu, Claudia Fattuoni, Francesco Delogu, Evelina Colacino, Maria Valeria D’Auria · 2022 · Green Chemistry
6. Emerging Roles for Histone Deacetylases in Pulmonary Hypertension and Right Ventricular Remodeling (2013 Grover Conference series)
   Maria A. Cavasin, Kurt R. Stenmark, Timothy A. McKinsey · 2015 · Pulmonary Circulation
7. Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids
   Quaovi H. Sodji, James R. Kornacki, John F. McDonald, Milan Mrksich, Adegboyega K. Oyelere · 2015 · European Journal of Medicinal Chemistry
8. Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors
   Rob De Vreese, Nicholas Van Steen, Tom Verhaeghe, Tom Desmet, Nadia Bougarne, Karolien De Bosscher, Veronick Benoy, Wanda Haeck, Ludo Van Den Bosch, Matthias D’hooghe · 2015 · Chemical Communications
9. Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function
   Julien Bricambert, Dimitri Favre, Saška Brajkovic, Amélie Bonnefond, Raphaël Boutry, Roberto Salvi, Valérie Plaisance, Mohamed Chikri, Giulia Chinetti, Bart Staels et al. · 2016 · Molecular Metabolism
10. Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
    Yuren Wang, Jason V. Wallach, Stephanie Duane, Yuan Wang, Jianghong Wu, Jeffrey Wang, Adeboye Adejare, Haiching Ma · 2017 · Drug Design Development and Therapy
11. Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor
    Nicholas J. Porter, Sida Shen, Cyril Bařinka, Alan P. Kozikowski, David W. Christianson · 2018 · ACS Medicinal Chemistry Letters
12. HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
    Hélène Losson, Michaël Schnekenburger, Mario A. Dicato, Marc F. Diederich · 2020 · Cancers
13. Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
    Yvonne Eileen Klingl, Donya Pakravan, Ludo Van Den Bosch · 2020 · British Journal of Pharmacology
14. Histone Deacetylase Inhibitors: Updated Studies in Various Epigenetic-Related Diseases
    Clemens Zwergel, Giulia Stazi, Sérgio Valente, Antonello Mai · 2016 · Journal of Clinical Epigenetics
15. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors
    Damodara N. Reddy, Flavio Ballante, Timothy Chuang, Adele Pirolli, Biagina Marrocco, Garland R. Marshall · 2015 · Journal of Medicinal Chemistry
16. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations
    Yudibeth Sixto‐López, Martiniano Bello, Rolando Alberto Rodríguez-Fonseca, Martha Cecilia Rosales‐Hernández, Marlet Martínez‐Archundia, José Antonio Gómez-Vidal, José Correa‐Basurto · 2016 · Journal of Biomolecular Structure and Dynamics
17. Honokiol ameliorates angiotensin II‐induced hypertension and endothelial dysfunction by inhibiting HDAC6‐mediated cystathionine γ‐lyase degradation
    Zhexi Chi, Truc Phan Hoang Le, Sang Ki Lee, Erling Guo, Dong‐Soo Kim, Sanha Lee, Seung‐Yong Seo, Sook Young Lee, Jae Hyung Kim, Sang Yoon Lee · 2020 · Journal of Cellular and Molecular Medicine
18. Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity
    Xinhui Zhang, Huiqin Kang, Yuanyuan Tao, Yihan Li, Junru Zhao, Ya-Gao, Liying Ma, Hong‐Min Liu · 2021 · European Journal of Medicinal Chemistry
19. Design, synthesis, and biological evalution of bifunctional inhibitors against Hsp90-HDAC6 interplay
    Hye Yun Chae, Sun You Park, Sonam Jha, Sunil Gupta, Mi Kyung Kim, Eunyoung Ha, Young Ho Seo · 2022 · European Journal of Medicinal Chemistry
20. Recent advances on the synthesis and application of tetrahydro-γ-carbolines
    Haibo Mei, Klára Aradi, Lóránd Kiss, Jianlin Han · 2023 · Chinese Chemical Letters
21. Inhibitors selective for HDAC6 in enzymes and cells
    Praveer K. Gupta, Robert C. Reid, Ligong Liu, Andrew J. Lucke, Steve Broomfield, Melanie R. Andrews, Matthew J. Sweet, David P. Fairlie · 2010 · Bioorganic & Medicinal Chemistry Letters
22. Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer’s Disease
    Luiz Antônio Soares Romeiro, Jéssica Larissa da Costa Nunes, Camila de Oliveira Miranda, Gabriella Simões Heyn Roth Cardoso, Andressa Souza de Oliveira, Annachiara Gandini, Tereza Kobrlová, Ondřej Soukup, Michele Rossi, Johanna Senger et al. · 2019 · ACS Medicinal Chemistry Letters
23. Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
    Bo Ram Han, Mengfei Wang, Jiayi Li, Qiushi Chen, Niubing Sun, Xuezhi Yang, Qingwei Zhang · 2023 · European Journal of Medicinal Chemistry
24. Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice
    Ping Bai, Yan Liu, Liuyue Yang, Weihua Ding, Prasenjit Mondal, Na Sang, Gang Liu, Xiaoxia Lü, Thanh Tu Ho, Yanting Zhou et al. · 2023 · Journal of Medicinal Chemistry
25. Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence
    Shiyu Zhang, Tianhai Lin, Xingyu Xiong, Chong Chen, Ping Tan, Qiang Wei · 2024 · Nature Reviews Urology
26. Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model
    Rosa Di Liddo, Sérgio Valente, Samanta Taurone, Clemens Zwergel, Biagina Marrocco, Rosaria Turchetta, Maria Teresa Conconi, Carlotta Scarpa, Thomas Bertalot, Sandra Schrenk et al. · 2016 · Autoimmunity
27. Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis
    Amir Zeb, Chanin Park, Shailima DV Rampogu, Minky Son, Gihwan Lee, Keun Woo Lee · 2018 · ACS Chemical Neuroscience
28. Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential
    Claartje Meddens, Amy C. J. van der List, Edward E. S. Nieuwenhuis, Michal Mokrý · 2019 · Gut
29. The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis
    Patrizia LoPresti · 2019 · Frontiers in Neurology
30. Inhibition of Histone Deacetylase 6 by Tubastatin A Attenuates the Progress of Osteoarthritis via Improving Mitochondrial Function
    Yijing Zheng, Yuemiao Chen, Xiaolang Lu, Qihao Weng, Gaole Dai, Yang Yu, Kehe Yu, Weiyang Gao · 2020 · American Journal Of Pathology
31. Targeting the HDAC6‐Cilium Axis Ameliorates the Pathological Changes Associated with Retinopathy of Prematurity
    Jie Ran, Yao Zhang, Sai Zhang, Haixia Li, Liang Zhang, Qingchao Li, Juan Qin, Dengwen Li, Lei Sun, Songbo Xie et al. · 2022 · Advanced Science
32. Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells
    J. Ptáček, Ivan Šnajdr, Jiří Schimer, Zsófia Kutil, Jana Mikesova, Petra Baranová, Barbora Havlínová, W. TUECKMANTEL, Pavel Majer, Alan P. Kozikowski et al. · 2023 · International Journal of Molecular Sciences
33. High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibility
    Samantha G. Pattenden, Jeremy M. Simon, Aminah Wali, Chatura N. Jayakody, Jacob A. Troutman, Andrew W. McFadden, Joshua Wooten, Cameron C. Wood, Stephen V. Frye, William P. Janzen et al. · 2016 · Proceedings of the National Academy of Sciences
34. HDAC6 inhibition prevents TNF-α-induced caspase 3 activation in lung endothelial cell and maintains cell-cell junctions
    Jinyan Yu, Mengshi Ma, Zhongsen Ma, Jian Fu · 2016 · Oncotarget
35. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Drosophila
    Chuan‐Xi Mao, Xue Wen, Shan Jin, Yongqing Zhang · 2017 · Disease Models & Mechanisms
36. Epigenetic modulation by small molecule compounds for neurodegenerative disorders
    Akash Kumar Singh, Sarmistha Halder-Sinha, James Premdoss Clement, Tapas Kumar Kundu · 2018 · Pharmacological Research
37. Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
    Annabelle Schlüter, Bahar Aksan, Rossella Fioravanti, Sérgio Valente, Antonello Mai, Daniela Mauceri · 2019 · Molecular Neurobiology
38. Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging
    Qian Li, Yushi Ma, Yunyan Zhu, Ting Zhang, Yanheng Zhou · 2016 · Journal of Periodontology
39. Orthogonal Syntheses of γ-Carbolinone and Spiro[pyrrolidinone-3,3′]indole Derivatives in One Pot through Reaction Telescoping
    Souvik Guha, Satyanarayana Gadde, Naresh Kumar, David StC. Black, Subhabrata Sen · 2021 · The Journal of Organic Chemistry
40. Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis
    Wei-Chieh Yu, T.Y. Yeh, Chih-Hung Ye, Patrick Chun Theng Chong, Yi-Hsun Ho, Dorothy Kazuno So, Kah Yi Yap, Guan-Ru Peng, Chi-Hsuan Shao, Ajit Dhananjay Jagtap et al. · 2023 · Journal of Medicinal Chemistry
41. Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer
    Adam D. Steg, Mata R. Burke, Hope M. Amm, Ashwini A. Katre, Zachary C. Dobbin, Dae Hoon Jeong, Charles N. Landen · 2014 · Oncotarget
42. Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors
    Liang Tao, Xuben Hou, Yi Zhou, Xinying Yang, Hao Fang · 2019 · ACS Medicinal Chemistry Letters
43. Effects of fasting on corticosterone production by zona fasciculata-reticularis cells in ovariectomized rats.
    Lingling Chang, Mei‐Mei Kau, Wan-Song Alfred Wun, Low-Tone Ho, Paulus S. Wang · 2002 · PubMed
44. Selective Targeting of Epigenetic Readers and Histone Deacetylases in Autoimmune and Inflammatory Diseases: Recent Advances and Future Perspectives
    Ghiboub, Mohammed, Elfiky, Ahmed M. I., de Winther, Menno P. J., Harker, Nicola R., Tough, David F., de Jonge, Wouter J. · 2021 · Journal of Personalized Medicine
45. ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A
    Prabhat Shrestha, Ramesh Duwa, Sooyeun Lee, Taeg Kyu Kwon, Jee‐Heon Jeong, Simmyung Yook · 2024 · European Journal of Pharmaceutical Sciences
46. Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity
    Priyanka Shailendra Rana, James John Ignatz-Hoover, Chunna Guo, Amber L. Mosley, Ehsan Malek, Yuriy Federov, Drew Adams, James Joseph Driscoll · 2024 · Molecular Cancer Therapeutics
47. Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
    Tago, Tetsuro, Toyohara, Jun · 2018 · Molecules
48. Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors
    Mitsuaki Yamashita, Teruyuki Tahara, Shinya Hayakawa, Hironobu Matsumoto, Shun‐ichi Wada, Kiyoshi Tomioka, Akira Iida · 2018 · Bioorganic & Medicinal Chemistry
49. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes
    Maxim V. Kozlov, Alla A. Kleymenova, Konstantin A. Konduktorov, Alsu Z. Malikova, Sergey N. Kochetkov · 2014 · Biochemistry (Moscow)
50. AMP Kinase Activation Alters Oxidant-Induced Stress Granule Assembly by Modulating Cell Signaling and Microtubule Organization
    Hicham Mahboubi, Antonis E. Koromilas, Ursula Stochaj · 2016 · Molecular Pharmacology
51. Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration
    Toshifumi Fukuda, Shigeru Yanagi · 2017 · Cellular and Molecular Life Sciences
52. Discovery of a fluorescent probe with HDAC6 selective inhibition
    Yingjie Zhang, Yan Jin, Tso‐Pang Yao · 2017 · European Journal of Medicinal Chemistry
53. An Overview of HDAC Inhibitors and their Synthetic Routes
    Xiaopeng Peng, Guochao Liao, Pinghua Sun, Zhiqiang Yu, Jianjun Chen · 2019 · Current Topics in Medicinal Chemistry
54. Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer
    Zhao, Jin, Bai, Hangming, Li, Xiaoyu, Yan, Jie, Zou, Gengyi, Wang, Longlong, Li, Xiru, Liu, Ze, Xiang, Rong, Yang, Xiang-Lei et al. · 2021 · Signal Transduction and Targeted Therapy
55. Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy
    Matthew S. Stratton, Timothy A. McKinsey · 2014 · Biochemistry and Cell Biology
56. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects
    Jiefei Miao, Yanfu Peng, Shi Chen, Weijie Gao, Qiuxing Yang, Peng Wei Zhu, Jing Guo, Jinhua Tao, Lin Luo, Yanan Zhang et al. · 2018 · European Journal of Pharmacology
57. Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol‐3‐kinase (PI3K): Current and Future Prospects
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Carlos Alberto Manssour Fraga · 2020 · ChemMedChem
58. Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity
    Shunda Li, Chunlong Zhao, Guozhen Zhang, Qifu Xu, Qian Liu, Wei Zhao, C. James Chou, Yingjie Zhang · 2021 · Bioorganic Chemistry
59. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases
    Lan Zhang, Yi Liu, Yingying Lu, Guan Wang · 2022 · Biochemical Pharmacology
60. A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
    Endan Li, Jiwoo Choi, Hye‐ri Sim, J.-H. Kim, Jae Hyun Jun, Jangbeen Kyung, Nina Ha, Semi Kim, Keun Ho Ryu, Seungsoo Chung et al. · 2023 · BMB Reports
61. Histone deacetylase inhibition reduces cardiac connexin43 expression and gap junction communication
    Qin Xu, Xianming Lin, Laura E. Andrews, Dakshesh Patel, Paul D. Lampe, Richard D. Veenstra · 2013 · Frontiers in Pharmacology
62. The Nervous System Cytoskeleton under Oxidative Stress
    John C. Gardiner, Robyn L. Overall, Jan Marc · 2013 · Diseases
63. Therapeutic prospects for epigenetic modulation
    Tom D. Heightman · 2011 · Expert Opinion on Therapeutic Targets
64. JMJD5 (Jumonji Domain-containing 5) Associates with Spindle Microtubules and Is Required for Proper Mitosis
    Zhimin He, Junyu Wu, Xiaonan Su, Ye Zhang, Lixia Pan, Huimin Wei, Qiang Fang, Haitao Li, Da-Liang Wang, Fang-Lin Sun · 2015 · Journal of Biological Chemistry
65. Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms
    Kunal Nepali, Hsueh‐Yun Lee, Mei-Jung Lai, Ritu Ojha, Tung-Yun Wu, Gu-Xian Wu, Mei-Chuan Chen, Jing‐Ping Liou · 2016 · European Journal of Medicinal Chemistry
66. A highly HDAC6-selective inhibitor acts as a fluorescent probe
    Yi-Hsun Ho, Kuang-Jui Wang, Pei-Yun Hung, Yi‐Sheng Cheng, Jia-Rong Liu, Sheang-Tze Fung, Pi‐Hui Liang, Ji‐Wang Chern, Chao‐Wu Yu · 2018 · Organic & Biomolecular Chemistry
67. Afadin is a scaffold protein repressing insulin action via HDAC6 in adipose tissue
    Morten Lundh, Patricia S. S. Petersen, Marie Sophie Isidor, Dolly NM Kazoka‐Sørensen, Kaja Plucińska, Farnaz Shamsi, Cathrine Ørskov, Marco Tozzi, Erin Louise Brown, Emil Andersen et al. · 2019 · EMBO Reports
68. Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
    Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs · 2013 · Journal of Alzheimer s Disease
69. Tetrahydro-β-carboline derivatives as potent histone deacetylase 6 inhibitors with broad-spectrum antiproliferative activity
    Xin Chen, Jiayun Wang, Peng Zhao, Baiyun Dang, Ting Liang, Raphael R. Steimbach, Aubry K. Miller, Jia Liu, Xin Wang, Tongtong Zhang et al. · 2023 · European Journal of Medicinal Chemistry
70. Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies
    Yudibeth Sixto‐López, José Antonio Gómez-Vidal, José Correa‐Basurto · 2014 · Applied Biochemistry and Biotechnology
71. Synthesis of N′-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV)
    Maxim V. Kozlov, Konstantin A. Konduktorov, Anastasia S. Shcherbakova, Sergey N. Kochetkov · 2019 · Bioorganic & Medicinal Chemistry Letters
72. Mixed alkoxy/hydroxy 1,8-naphthalimides: expanded fluorescence colour palette and in vitro bioactivity
    Elley E. Rudebeck, Rosalind P. Cox, Toby D. M. Bell, Rameshwor Acharya, Zikai Feng, Nuri Gueven, Trent D. Ashton, Frederick Matthew Pfeffer · 2020 · Chemical Communications
73. New insights into the role and therapeutic potential of HSP70 in diabetes
    Amanda Almeida de Oliveira, Valentina Ochoa Mendoza, Swasti Rastogi, Kênia Pedrosa Nunes · 2022 · Pharmacological Research
74. Development of an ELISA-Based HDAC Activity Assay for Characterization of Isoform-Selective Inhibitors
    Geetha Padige, Ahmed T. Negmeldin, Mary Kay H. Pflum · 2015 · SLAS DISCOVERY
75. Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors
    Rob De Vreese, Yves Depetter, Tom Verhaeghe, Tom Desmet, Veronick Benoy, Wanda Haeck, Ludo Van Den Bosch, Matthias D’hooghe · 2016 · Organic & Biomolecular Chemistry
76. Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model
    Panpan Chang, Michael B. Weykamp, Isabel S. Dennahy, Aaron M. Williams, Umar Farooq Bhatti, Baoling Liu, Vahagn C. Nikolian, Yongqing Li, Hasan Badre Alam · 2018 · The Journal of Trauma: Injury, Infection, and Critical Care
77. SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules
    Fang Wang, Li Zheng, Yuyao Yi, Zhuang Yang, Qiang Qiu, Xiaoyan Wang, Wei Yan, Peng Bai, Jianhong Yang, Dan Li et al. · 2018 · Molecular Cancer Therapeutics
78. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
    Jinhui Hu, Baijiao An, Tingting Pan, Zhengcunxiao Li, Ling Huang, Xingshu Li · 2018 · Bioorganic & Medicinal Chemistry
79. Histone Deacetylase Inhibitor SAHA Treatment Prevents the Development of Heart Failure after Myocardial Infarction via an Induction of Heat-Shock Proteins in Rats
    Shiho Nagata, Tetsuro Marunouchi, Kouichi Tanonaka · 2019 · Biological and Pharmaceutical Bulletin
80. Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
    Gustavo Salgado Pires, Heber Victor Tolomeu, Daniel Alencar Rodrigues, Lı́dia Moreira Lima, Carlos Alberto Manssour Fraga, Pedro de Sena Murteira Pinheiro · 2025 · Pharmaceuticals
81. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism
    Weston W. Blakeslee, Christina L. Wysoczynski, Kristofer S. Fritz, Jennifer K. Nyborg, Mair E. A. Churchill, Timothy A. McKinsey · 2014 · Cellular Signalling
82. NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling
    Ana Martín-Hurtado, Raquel Martin-Morales, Natalia Robledinos-Antón, Ruth Blanco, Ines Palacios-Blanco, Isabel Lastres‐Becker, Antonio Cuadrado, Francesc R. García-Gonzalo · 2019 · Scientific Reports
83. Tubastatin A maintains adult skeletal muscle stem cells in a quiescent state ex vivo and improves their engraftment ability in vivo
    Marina Arjona, Armon Goshayeshi, Cristina Rodríguez-Mateo, Jamie O. Brett, Pieter Both, Heather D. Ishak, Thomas A. Rando · 2022 · Stem Cell Reports
84. Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities
    Ting Liang, Zhao Xie, Baiyun Dang, Jiayun Wang, Tongtong Zhang, Xiaofa Luan, Tao Lu, Chenyu Cao, Xin Chen · 2023 · Bioorganic & Medicinal Chemistry Letters
85. Pharmacophore and QSAR Studies to Design Novel Histone Deacetylase 2 Inhibitors
    Yuhong Xiang, Zhaoyan Hou, Zhuoyong Zhang · 2012 · Chemical Biology & Drug Design
86. Synthesis of fused-tricyclic indole derivatives through an acid-promoted skeletal rearrangement
    Takuya Yokosaka, Tomoya Kanehira, Hiroki Nakayama, Tetsuhiro Nemoto, Yasumasa Hamada · 2014 · Tetrahedron
87. HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation
    Zhang, Qian-qian, Zhang, Wei-jie, Chang, Sheng · 2023 · Frontiers in Immunology
88. Crafting Carbazole-Based Vorinostat and Tubastatin-A-like Histone Deacetylase (HDAC) Inhibitors with Potent in Vitro and in Vivo Neuroactive Functions
    R. Gajendra Reddy, Goverdhan Surineni, Dwaipayan Bhattacharya, Sandeep Kumar Marvadi, Arpita Sagar, Arunasree Marasanapalli Kalle, Arvind Kumar, Srinivas Kantevari, Sumana Chakravarty · 2019 · ACS Omega
89. A bionic multichannel nanofiber conduit carrying Tubastatin A for repairing injured spinal cord
    Shiyang Liao, Yonghang Liu, Yanlong Kong, Haitao Shi, Bitong Xu, Bo Tang, Congbin Li, Yitian Chen, Jing Chen, Juan Du et al. · 2022 · Materials Today Bio
90. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
    Ana M. Vuletić, Katarina Mirjačić Martinović, Jelena Spasić · 2023 · Pharmaceutics
91. Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
    Miroslava Čuperlović‐Culf, Mohamed Touaibia, Patrick‐Denis St‐Cœur, Julie Poitras, Pier Morin, Adrian S. Culf · 2014 · Metabolites
92. Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock
    Zhigang Chang, Yongqing Li, Wei He, Baoling Liu, Xiuzhen Duan, Ihab F. Halaweish, Ted Bambakidis, Baihong Pan, Yingjian Liang, Vahagn C. Nikolian et al. · 2016 · The Journal of Trauma: Injury, Infection, and Critical Care
93. Highly fluorescent and HDAC6 selective scriptaid analogues
    Cassandra L. Fleming, Anthony L. Natoli, Jeannette Schreuders, Mark G. Devlin, Prusothman Yoganantharajah, Yann Gibert, Kathryn G. Leslie, Elizabeth J. New, Trent D. Ashton, Frederick Matthew Pfeffer · 2018 · European Journal of Medicinal Chemistry
94. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin‐induced acute lung injury
    Anita Kovács‐Kása, László Kovács, Mary Cherian‐Shaw, Vijay S Patel, Mary Louise Meadows, David J. Fulton, Yunchao Su, Alexander D. Verin · 2020 · Journal of Cellular Physiology
95. Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease
    Wang, Xiu-Xiu, Xie, Fei, Jia, Cong-Cong, Yan, Ning, Zeng, Yan-Li, Wu, Jing-De, Liu, Zhao-Peng · 2021 · European Journal of Medicinal Chemistry
96. Diverse pharmacological activities of β-carbolines: Substitution patterns, SARs and mechanisms of action
    Muneeb Ur Rehman, Yujie Zuo, Ni Tu, Ju Guo, Ziwei Liu, Shuang Cao, Sihui Long · 2025 · European Journal of Medicinal Chemistry
97. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model
    Ting Zhao, Yongqing Li, Roderick Terry Bronson, Baoling Liu, George C. Velmahos, Hasan Badre Alam · 2014 · Surgery
98. Histone Deacetylases As Targets for Antitrypanosomal Drugs
    Aline Araújo Zuma, Wanderley de Souza · 2018 · Future Science OA
99. Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
    Edoardo Parrella, Vanessa Porrini, Ilaria Scambi, Michele Mario Gennari, Cristina Gussago, Oluwamolakun O. Bankole, Marina Benarese, Raffaella Mariotti, Marina Pizzi · 2022 · Frontiers in Pharmacology
100. Identification of a novel PAK1/HDAC6 dual inhibitor ZMF-23 that triggers tubulin-stathmin regulated cell death in triple negative breast cancer
     Jin Zhang, Xiya Chen, Gang Chen, Hailing Wang, Lin Jia, Hao Yue, Dahong Yao · 2023 · International Journal of Biological Macromolecules